The B2B Podcast Index
Index
All categories
MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
MethodologySubmit
Best of:MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
An independent project byFame
All showsSearchBest episodesGuestsInsightsMethodologySubmit a podcast
#38Power to the Patients87.0 / 100Get badge
← The Index
Power to the Patients artwork
GeneralNEW this period

Power to the Patients

Hosted by Brandon Li

Listed under Science › Life Sciences

Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials.

59 episodes · publishes fortnightly · latest 2026-11-05 · ~42 min/episode

Rank

#38

Substance

87.0

/ 100

Breakdown

Scored 2026-11
Updated monthly

General rank

#8 of 301

Across the index

#38 of 6228

Substance

Top 1%

outscores 99% of the index

Why it scores where it does

Power to the Patients ranks #38 on The B2B Podcast Index with a substance score of 87.0 out of 100, scored across 1 recent episode. It scores highest on guest caliber and specificity & evidence. Both guests are credible practitioners: one ran failed autism trials at Cincinnati Children's and leads Fragile X work, the other worked on amyloid programs at Roche and digital health at Amgen.

The five-dimension breakdown

Averaged across 1 recently scored episode, with cited evidence.

Insight Density

17.0 / 20

Strong technical substance on trial de-risking with quantitative biomarkers, the amyloid-efficacy gap, and a peripherally-restricted beta-blocker pairing mechanism, though value for a general B2B operator is narrow and a large block of content is verbatim duplicated.

“we did high density EEG study to see what brain electrical activity change was happening”

“we've coupled our beta 2 agonist with a peripherally restricted beta blocker, nadalol”

Originality

17.0 / 20

Genuinely contrarian stance that approved anti-amyloid drugs are not meaningfully disease-modifying, plus a first-principles argument for placebo-resistant objective endpoints over large symptomatic trials.

“I don't believe that. I don't think we're seeing disease modification”

“how can we use biologic markers of brain function that are quantitative and placebo resistant”

Guest Caliber

19.0 / 20

Both guests are credible practitioners: one ran failed autism trials at Cincinnati Children's and leads Fragile X work, the other worked on amyloid programs at Roche and digital health at Amgen.

“when I was at Roche, uh, back in 2008, 2009 and I was in Basel for three years at Roche headquarters”

“I've been involved, for example, in autism with every negative, double blind, placebo controlled, multisite, large scale trial”

Specificity & Evidence

19.0 / 20

Dense with named drugs, mechanisms, and hard numbers - CDR sum-of-boxes thresholds, recognition rates, familial vs sporadic percentages - giving concrete evidence throughout.

“What they got in their studies was slightly less than 0.5”

“about a 70% recognition uh rate, patients depressed will score about 40%”

Conversational Craft

15.0 / 20

The host lands one genuinely probing challenge, but as a stitched 'best of' compilation most prompts are high-level lobs with little real-time follow-up or pushback.

“If I may be difficult for a moment, this sounds ideal. Why doesn't everyone else do it this way”

“Let me just lob a high, uh, level question. Your way to start. Why synapses?”

Standout episodes

  • Why Neuroscience Trials Keep Failing and What Could Fix Them

    2026-11-05

    87

Rank over time

First period on the Index - history builds from here.

Episodes

1 scored on substance · 30 tracked in total.

  • Why Neuroscience Trials Keep Failing and What Could Fix Them

    2026-11-05 · 30 min

    87 / 100

Frequently asked

What is Power to the Patients's substance score?
Power to the Patients scores 87.0 out of 100 for substance and ranks #38 on The B2B Podcast Index. That puts it ahead of 99% of the B2B podcasts we rank and #8 of 301 in General. The score reflects insight density, originality, guest caliber, specificity and conversational craft across recent episodes - not downloads.
Is Power to the Patients worth listening to?
Yes - Power to the Patients outscores 99% of the B2B general podcasts and shows we rank on substance, so a general operator is likely to come away with something useful.
Who hosts Power to the Patients?
Power to the Patients is hosted by Brandon Li.
How often does Power to the Patients publish?
Power to the Patients publishes fortnightly, has 59 episodes, released its most recent episode on 2026-11-05.
Which Power to the Patients episode should I start with?
Our highest-scoring recent episode is "Why Neuroscience Trials Keep Failing and What Could Fix Them" (87/100) - a good place to start.

Show off your #8 rank in General

Add this badge to your site - it links back here and updates automatically as you rank.

Ranked #8 on The B2B Podcast Index
Embed code
<a href="https://index.fame.so/show/power-to-the-patients" target="_blank" rel="noopener">
  <img src="https://index.fame.so/badge/power-to-the-patients/badge.svg" alt="Ranked #8 on The B2B Podcast Index" width="360" height="136" />
</a>
Markdown & other formats →

Track Power to the Patients's rank

Get an email whenever this show moves up or down the Index. Monthly at most, no spam.

Listen / subscribe:WebsiteSpotifyYouTubeRSS

Guests who've appeared

Craig EricksonGabriel Vargas

Topics this show covers

The themes that come up most across this show's episodes.

Power To The Patients · 7Brain Health · 3neuroscience · 3Alzheimers Disease · 2drug development · 2postpartum depression · 2Clinical trials · 2Psychiatry Innovation · 2Neurodegeneration · 2LecanemabNeuroscience drug developmentCraig Erickson SpinogenixGabriel Vargas CuraSen TherapeuticsFragile X syndrome (FXS) treatmentSPG601 clinical trialHigh-density EEGComputer-based performance testingFragile X syndrome

More General podcasts

  • The Reality Layer

    Nearmap

    87.0
  • CareTalk: Healthcare. Unfiltered.

    CareTalk: Healthcare. Unfiltered.

    85.0
  • The AI in Business Podcast

    Daniel Faggella

    79.0
  • Motley Fool Hidden Gems Investing

    The Motley Fool

    77.0
  • The TreppWire Podcast: A Commercial Real Estate Show

    The TreppWire Podcast, A CRE Show

    76.5
  • Finding Peak w/ Ryan Hanley

    Ryan Hanley

    75.0

Similar shows

Podcasts that dig into the same topics.

  • Progress, Potential, and Possibilities Podcast / Show

    Ira Pastor

  • Heart of the Matter

    Partnership to End Addiction

  • CareTalk: Healthcare. Unfiltered.

    CareTalk: Healthcare. Unfiltered.

    85.0
  • Success Leaves Clues with Robin Bailey and Al McDonald

    A Starting with One Podcast

  • Leadership Performance Under Pressure

    Dex Randall | Leadership Performance Coach

  • Excellence In Healthcare Podcast

    Jarvis T. Gray